Immunomodulatory effects of cigarette smoke

Journal of Neuroimmunology

Volumn 83, Issue 1-2, 1998, Pages 148-156

  Sopori, Mohan L ^a   Kozak, Wieslaw ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Cigarette smoke; Immune response; Inflammation; Neuroimmune modulation; Nicotine

Indexed keywords

CYTOKINE; NICOTINE; TOBACCO SMOKE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CIGARETTE SMOKING; CLONAL ANERGY; HUMAN; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

HUMANS; NEUROIMMUNOMODULATION; NICOTINE; NICOTINIC AGONISTS; SMOKING;

EID: 0032520697     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00231-2     Document Type: Article

References (112)

1. Abbud R.A., Finegan C.K., Guay L.A., Rich E.A. Enhanced production of human immunodeficiency virus type-1 by in vitro infected alveolar macrophages from otherwise healthy cigarette smokers. J. Infec. Dis. 172:1995;859-863.
2. Adesina A.M., Vallyathan V., McQuillen, Weaver S.O., Craighead J.E. Bronchiolar inflammation and fibrosis associated with smoking. Am. Rev. Respir. Dis. 143:1991;144-149.
3. Andersen P., Pedersen D.F., Bach B., Bonde G.J. Serum immunoglobulins in smokers and non-smokers. Clin. Exp. Immunol. 47:1982;467-473.
4. Archuleta M.M., Schieven G.L., Ledbetter J.A., Deanin G.G., Burchiel S.W. 7,12-dimethylbenz[a]anthracene activates protein-tyrosine kinases Fyn and Lck in the HPB-ALL human T-cell line and increases tyrosine phosphorylation of phospholipase C-γ1, formation of inositol 1,4,5-trisphosphate, and mobilization of intracellular calcium. Proc. Natl. Acad. Sci. U.S.A. 90:1993;6105-6109.
5. Arendash G.W., Sengstock G.J., Sandberg R.R., Kem W.R. Improved learning and memory in aged rats with chronic administration of nicotinic receptor agonist GTS-21. Brain Res. 674:1995;242-259.
6. Aronson M., Weiss S., Ben R., Komaroff A. Association between cigarette smoking and acute respiratory tract illness in young adults. JAMA. 248:1982;181-183.
7. Ayer D.J., Keast D., Papadimitriou J.M. Effects of tobacco smoke on splenic architecture and weight, during the primary immune response of BALB/c mice. J. Pathol. 133:1981;53-59.
8. Bahna S.L., Heiner D.C., Myhre B.A. Immunoglobulin E pattern in cigarette smokers. J. Allergy Clin. Immunol. 38:1983;57-64.
9. Balkwill F. Cytokines in health and disease. Immunol. Today. 14:1993;149-150.
10. Berridge M.J. Inositol trisphosphate and calcium signaling. Nature. 361:1993;315-325.
11. Blalock J.E. The immune system, our sixth sense. Immunologist. 2:1994;8-15.
12. Bosken C.H., Hards J., Gatter K., Hogg J.C. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am. Rev. Respir. Dis. 145:1992;911-917.
13. Braubar N. Direct effects of nicotine on the brain, evidence for chemical addiction. Arch. Environ. Health. 50:1995;263-266.
14. Brooks S.M., Baker D.B., Gann P.H., Jarabek A.M., Hertzberg V., Gallagher J., Biagini R.E., Bernstein I.L. Cold air challenge and platinum skin reactivity in platinum refinery workers. Chest. 97:1990;1401-1407.
15. Brown G.P., Iwamoto G.K., Monick M.M., Hunninghake G.W. Cigarette smoking decreases interleukin-1 release by human alveolar macrophages. Am. J. Physiol. 256:1989;C260-C264.
16. Burns D.N., Kramer A., Yellin F., Fuchs D., Wachter H., DiGiora R.A., Sanchez W.C., Grossman R.J., Gordin F.M., Biggar R.J. Cigarette smoking, a modifier of human immunodeficiency virus type 1 infection? J. AIDS. 4:1991;76-83.
17. + levels. J. AIDS. 7:1994;718-726.
18. Burrows B., Lebowitz M.D., Barbee R.A. Respiratory disorders and allergy skin test reactions. Ann. Int. Med. 84:1976;134-139.
19. Burrows B., Halonen M., Barbee R.A., Lebowitz M.D. The relationship of serum immunoglobulin E to cigarette smoking. Am. Rev. Respir. Dis. 124:1981;523-525.
20. Burrows B., Halonen M., Lebowitz M.D., Knudson R.J., Barbee R.A. The relationship of serum immunoglobulin E, allergy skin test, and smoking to respiratory disorders. J. Allergy Clin. Immunol. 70:1982;199-204.
21. Byron K.A., Varigos G.A., Wootton A.M. IL-4 production is increased in cigarette smokers. Clin. Exp. Immunol. 95:1994;333-336.
22. Cambier J.C., Pleiman C.M., Clark M.R. Signal transduction by the B cell antigen receptor and its co-receptors. Ann. Rev. Immunol. 12:1994;457-486.
23. Casale G.P., Cohen S.D., DiCapua R.A. The effects of organophosphate-induced cholinergic stimulation on the antibody response to sheep erythrocytes in inbred mice. Toxicol. Appl. Pharmacol. 68:1983;198-205.
24. Catania A., Airaghi L., Manfredi M.G., Vivirito M.C., Milazzo F., Lipton J.M., Zanussi C. Proopiomelanocortin-derived peptides and cytokines, relations in patients with acquired immunodeficiency syndrome. Clin. Immunol. Immunopathol. 66:1993;73-79.
25. Chalmer J., Holt P.G., Keast D. Cell-mediated immune response to transplanted tumors in mice chronically exposed to fresh cigarette smoke. J. Natl. Cancer Inst. 52:1975;1129-1134.
26. Chan A., Desai D., Weiss A. The role of tyrosine kinases and protein tyrosine phosphatases in the antigen receptor signal transduction. Ann. Rev. Immunol. 12:1994;555-592.
27. Clapham D.E. Calcium signaling. Cell. 80:1995;258-268.
28. Clerici M., Hakim F.T., Venzon D.J., Blatt S., Hendrix C.W., Wynn T.A., Shearer G.M. Changes in interleukin-2 and interleukin-4 produced in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:1993;759-765.
29. Corre F., Lellouch J., Schwartz D. Smoking and leukocyte counts. Results of an epidemiological survey. Lancet. 2:1971;632-634.
30. Craib K.J.P., Schechter M.T., Montaner J.S., Le T.N., Sestak P., Willoughby B., Voigt R., Haley L., O'Shaughnessy M.V. The effects of cigarette smoking on lymphocyte subsets and progression to AIDS in a cohort of homosexual men. Clin. Invest. Med. 15:1996;301-308.
31. Cryer P.E., Hymond M.W., Santiago J.V., Shah S.D. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N. Engl. J. Med. 295:1976;573-577.
32. Doll R., Peto R. Mortality in relation to smoking, 20 years observation on male British doctors. Br. Med. J. 2:1976;1525-1535.
33. Drazen J.M., Arm J.P., Austen K.F. Sorting out the cytokines of asthma. J. Exp. Med. 183:1996;1-5.
34. Dube M.F., Green C.R. Methods of collection of smoke for analytical purposes. Recent Adv. Tobacco Sci. 8:1982;42-102.
35. Fearon D.T., Locksley R.M. Instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-54.
36. Ferson M., Edwards A., Lind A., Milton G.W., Hershy P. Low natural killer-cell activity and immunoglobulin levels associated with smoking human subjects. Int. J. Cancer. 23:1979;603-609.
37. Finklea J., Sandifer S., Smith D. Cigarette smoking and epidemic influenza. Am. J. Epidemiol. 90:1969;390-399.
38. Francus T., Romano P.M., Manzo G., Fonacier L., Arango N., Szabo P. IL-1, IL-6, and PDGF mRNA expression in alveolar cells following stimulation with tobacco-derived antigen. Cell. Immunol. 145:1992;156-174.
39. Fuchs B.A., Sanders V.M. The role of brain-immune interaction in immunotoxicology. Crit. Rev. Toxicol. 24:1994;151-176.
40. Gajewski T.F., Qian D., Fields P., Fitch F.W. Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc. Natl. Acad. Sci. U.S.A. 91:1994;38-42.
41. Geng Y., Savage S.M., Johnson L.J., Seagrave J., Sopori M.L. Effects of nicotine on the immune response: I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Toxicol. Appl. Pharmacol. 135:1995;268-278.
42. Geng Y., Savage S.M., Razani-Boroujerdi S., Sopori M.L. Effects of nicotine on the immune response: II. Chronic nicotine treatment induces T cell anergy. J. Immunol. 156:1996;2384-2390.
43. Gerrard J.W., Heiner D.C., Ko C.G., Mink J., Meyers A., Dosman J.A. Immunoglobulin levels in smokers and non-smokers. Ann. Allergy. 44:1980;261-262.
44. Gordon S., Clarke S., Greaves D., Doyle A. Molecular immunobiology of macrophages, recent progress. Curr. Opin. Immunobiol. 7:1995;24-33.
45. Goud S.N., Kaplan A.M., Subbarao B. Effects of cigarette smoke on the antibody response to thymic independent antigens from different lymphoid tissues of mice. Arch. Toxicol. 66:1992;164-169.
46. Greber U., Gerace L. Depletion of calcium from the lumen of endoplasmic reticulum reversibly inhibits passive diffusion and signal-mediated transport into the nucleus. J. Cell Biol. 128:1995;5-14.
47. Guler M.L., Gorham J.D., Hsieh C.-S., Mackey A.J., Steen R.J., Dietrich W.F., Murphy K.M. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science. 271:1996;984-987.
48. Haynes W.F.J., Krstulovic V.J., Bell A.J. Smoking habit and incidence of respiratory tract infections in a group of adolescent males. Am. Rev. Respir. Dis. 93:1966;780-785.
49. Hirschtick R.E., Glassroth J., Jordan M.C., Wilcosky T.C., Wallace J.M., Kvale P.A., Markowitz N., Rosen M.J., Mangura B.T., Hopewell P.C. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary complication of HIV infection study group. N. Engl. J. Med. 333:1995;845-851.
50. Hoffmann D., Wynder E.L. Chemical constituents and bioactivity of tobacco smoke. IARC Sci. Publ. 74:1986;145-165.
51. Hoffmann D., Rivenson A., Hecht S.S., Hilfrich I., Kobayashi N., Wynder E.L. Model studies in tobacco carcinogenesis with Syrian golden hamster. Prog. Exp. Tumor Res. 24:1979;370-390.
52. Holt P.G. Immune and inflammatory function in cigarette smokers. Thorax. 42:1987;241-249.
53. Holt P.G., Keast D. Environmentally induced changes in immunological function, acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriol. Rev. 41:1977;205-216.
54. Holt P.G., Chalmer J., Roberts L.M., Papadimitriou J.M., Thomas W.R., Keast D. Low-tar high-tar cigarettes, comparison of effects in mice. Arch. Environ. Health. 31:1976;258-265.
55. + T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547-549.
56. Hughes D.A., Haslam P.L., Townsend P.J., Turner-Warwick M. Numerical and functional alteration in circulatory lymphocytes in cigarette smokers. Clin. Exp. Immunol. 61:1985;459-466.
57. James J.R., Nordberg A. Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders, emphasis on Alzheimer's disease. Behav. Genetics. 25:1995;149-159.
58. Johnson J.D., Hauchens D.P., Kluwe W.M., Craig D.K., Fisher G.L. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans, a review. Crit. Rev. Toxicol. 20:1990;369-395.
59. 1) influenza in young men. N. Engl. J. Med. 307:1982;1042-1046.
60. Kaufmann S.H.E. Immunity to intracellular microbial pathogens. Immunol. Today. 16:1995;338-342.
61. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell. 76:1994;253-262.
62. Kuhn R., Rajewsky K., Muller W. Generation and analysis of interleukin-4 deficient mice. Science. 254:1991;707-710.
63. London E.D., Connolly R.J., Szikszay M., Wamsley J.K. Distribution of cerebral metabolic effects of nicotine in the rat. Eur. J. Pharmacol. 110:1985;391-392.
64. 3H]-nicotine binding sites in the rat brain. Neurosci. Lett. 53:1985;179-184.
65. Mackenzie J.S. The effects of cigarette smoke on influenza virus, a murine model system. Life Sci. 19:1976;409-412.
66. Madrenas J., Wange R.L., Wang J.L., Isakov N., Samelson L.E., Germain R.N. ξ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science. 267:1995;515-518.
67. Manetti R., Parronchi P., Giudizi M.G., Piccinni M.P., Maggi E., Trinchieri G., Romagnani S. Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits development of IL-4 producing cells. J. Exp. Med. 177:1993;1199-1204.
68. Marrack P., Kappler J. Subversion of immune system by pathogens. Cell. 76:1994;323-332.
69. Matta S.G., Foster C.A., Sharp B.M. Nicotine stimulates the expression of c-fos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. Endocrinology. 132:1993;2149-2156.
70. McCrea K.A., EnSor J.E., Nall K., Bleecker E.R., Hasday J.D. Altered cytokine regulation in the lungs of cigarette smokers. Am. J. Respir. Crit. Care Med. 150:1994;696-703.
71. Meguro K., Yamaguchi S., Arai H., Nagagawa T., Maruyama Y., Sasaki H. Nicotine improves cognitive disturbance in senescence-accelerated mice. Pharmacol. Biochem. Behav. 49:1994;769-772.
72. Mills C.M., Hill S.A., Marks R. Altered inflammatory responses in smokers. Br. Med. J. 307:1993;911.
73. Mosmann T.R., Coffman R.L. TH1 and TH2 cells, different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 7:1989;145-173.
74. Nieman R.B., Fleming J., Cocker R.J., Harris J.R., Mitchell D.M. The effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS. 7:1993;705-710.
75. Nobe-Trauth N., Kropf P., Muller I. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science. 271:1996;987-990.
76. Park L.P., Margolick J.B., Giorgi J.V., Ferbs J., Bauer K., Kaslow R., Munoz A. Influence of HIV-1 infection and cigarette smoking on leukocyte profiles in homosexual men. The multi-center AIDS cohort study. J. AIDS. 5:1992;1124-1130.
77. Pearce E.J., Reiner S.L. Induction of Th2 responses in infectious diseases. Curr. Opin. Immunol. 7:1995;497-504.
78. Plowman P.N. The pulmonary macrophage population of human smokers. Am. Rev. Respir. Dis. 25:1982;393-405.
79. Pomerleau O.F., Festing J.B., Seyler L.E., Jaffe J. Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology. 81:1983;61-67.
80. Sauty A., Mauel J., Philippeaux M.-M., Leuenberger P. Cytostatic activity of alveolar macrophages from smokers and non-smokers, Role of interleukin-1β, interleukin-6, and tumor necrosis factor-α Am. J. Respir. Cell Mol. Biol. 11:1994;631-637.
81. Savage S.M., Donaldson L.A., Cherian S., Chilukuri R., White V.A., Sopori M.L. Effects of cigarette smoke on the immune response: II. chronic exposure to cigarette smoke inhibits surface immunoglobulin-mediated responses in B cells. Toxicol. Appl. Pharmacol. 111:1991;523-529.
82. Schnizlein C.T., Bice D.E., Mitchell C.E., Hahn F.F. Effects on rat lung immunity by acute lung exposure to benzo[a]pyrene. Arch. Environ. Health. 37:1982;201-206.
83. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10188-10192.
84. Seyler L.E. Jr., Fertig J.B., Pomerleau O.F., Hunt D., Parker K. The effects of smoking on ACTH and cortisol secretion. Life Sci. 34:1984;57-65.
85. Seyler L.E. Jr., Pomerleau O.F., Fertig J.B., Hunt D., Parker K. Pituitary hormone response to cigarette smoking. Pharmacol. Biochem. Behav. 24:1986;159-162.
86. Sher A., Ahmed R. Immunity to infection. Curr. Opin. Immunol. 7:1995;471-473.
87. Sloan-Lancaster J., Shaw A.S., Rothbard J.B., Allen P.M. Partial T cell signaling, altered phospho-ξ and lack of ZAP-70 recruitment in APL-induced T cell anergy. Cell. 79:1994;913-922.
88. Smart Y.C., Cox J., Roberts T.K., Brinsmead M.W., Burton R.C. Differential effects of cigarette smoke on recruiting T lymphocyte subsets in pregnant women. J. Immunol. 137:1986;1-3.
89. Soliman D.M., Twigg H.L. III Cigarette smoke decreases bioactive interleukin-6 secretion by alveolar macrophages. Am. J. Physiol. 263:1992;L471-L478.
90. Sopori M.L., Gairola C.G., DeLucia A.J., Bryant L.R., Cherian S. Immune responsiveness of monkeys exposed chronically to cigarette smoke. Clin. Immunol. Immunopathol. 36:1985;338-344.
91. Sopori M.L., Cherian S., Chilukuri R., Shopp G.M. Cigarette smoke causes inhibition of the immune response to intratracheally administered antigens. Toxicol. Appl. Pharmacol. 97:1989;489-499.
92. Sopori M.L., Savage S.M., Christner R.F., Geng Y., Donaldson L.A. Cigarette smoke and the immune response, mechanism of nicotine-induced immunosuppression. Adv. Biosci. 86:1993;663-672.
93. Sopori, M.L., Goud, N.S., Kaplan, A.M., 1994. Effects of tobacco smoke on the immune system. In: Dean, J.H., Luster, M.I., Munson, A.E., Kimber, I. (Eds.), Immunotoxicology and Immunopharmacology, Raven Press, New York, pp. 413-434.
94. Stedman R.L. The chemical composition of tobacco and tobacco smoke. Chem. Rev. 68:1968;153-207.
95. Thomas W.R., Holt P.G., Keast D. Effects of cigarette smoking on primary and secondary humoral responses in mice. Nature. 243:1973;240-241.
96. Thomas W.R., Holt P.G., Keast D. Cellular immunity in mice chronically exposed to fresh cigarette smoke. Arch. Environ. Health. 27:1973;372-375.
97. Thomas W.R., Holt P.G., Keast D. The development of alteration in the primary immune response of mice by exposure to fresh cigarette smoke. Int. Arch. Allergy Appl. Immunol. 46:1974;481-486.
98. Thomas W.R., Holt P.G., Papadimitriou J.M., Keast D. The growth of transplanted tumors in mice after chronic inhalation of fresh cigarette smoke. Br. J. Cancer. 30:1974;459-462.
99. Tollerud D.J., Clark J.W., Brown L.M., Neuland C.Y., Mann D.L., Pankiw-Trost L.K., Blattner W.A., Hoover R.N. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am. Rev. Respir. Dis. 139:1989;194-198.
100. Tollerud D.J., Brown L.M., Blattner W.A., Mann D.L., Pankiw-Trost L., Hoover R.N. T cell subsets in healthy black smokers and non-smokers. Evidence for ethnic group as an important response modifier. Am. Rev. Respir. Dis. 144:1991;612-616.
101. Trinchieri G. Interleukin-12, a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immunol. 13:1995;251-276.
102. US Department of Health and Human Services, 1993. Respiratory health effects of passive smoking, lung cancer and other disorders, NIH Publication No. 93-3605, monograph 4.
103. US Department of Health and Human Services, 1994. CDC Morbidity and Mortality Weekly Report, Vol. 43, pp. 469-472.
104. US Department of Health, Education, and Welfare, 1979. A report of the Surgeon General: smoking and health, US Government Printing Office.
105. Van Dijk J.P., Madretsma G.S., Keuskamp Z.J., Zijlstra F.J. Nicotine inhibits cytokine synthesis by mouse colonic mucosa. Eur. J. Pharmacol. 278:1995;R11-R12.
106. Van Loon, G.R., Kiritsy-Roy, J.A., Brown, L.V., Bobbitt, F.A., 1987. Nicotinic regulation of sympathoadrenal catecholamine secretion, cross tolerance to stress. In: Martin, W.R., Van Loon, G.R., Iwamato, E.T., Davis, L. (Eds.), Tobacco Smoking and Nicotine, A Neurobiological Approach, Plenum, New York, pp. 263-276.
107. Weiss A., Littman D.R. Signal transduction by lymphocyte antigen receptors. Cell. 76:1994;263-274.
108. White K.L. Jr. An overview of immunotoxicology and carcinogenic polycyclic aromatic hydrocarbons. J. Environ. Sci. Health. C4:1986;163-202.
109. White, K.L. Jr., Kawabata, T.T., Ladics, G.S., 1994. Mechanism of polycyclic aromatic hydrocarbon immunotoxicity. In: Dean, J.H., Luster, M.I., Munson, A.E., Kimber I. (Eds.), Immunotoxicology and Immunopharmacology, Raven Press, New York, pp. 123-142.
110. Wick G., Schett G., Amberger A., Kleindienst R., Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol. Today. 16:1995;27-33.
111. Wilson A.L., Langley L.K., Monley J., Bauer T., Rottunda S., McFalla E., Kovera C., McCarten J.R. Nicotine patches in Alzheimer's disease, pilot study on learning, memory, and safety. Pharmacol. Biochem. Behav. 51:1995;509-514.
112. Yamaguchi E., Okazaki N., Itoh A., Abe S., Kawakami Y., Okuyama H. Interleukin-1 production by alveolar macrophages decreased in smokers. Am. Rev. Respir. Dis. 140:1989;397-402.